These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19746203)

  • 1. Lymphangitic carcinomatosis as a cause of malignant transient pleural transudate.
    Garcia Sevila R; Barroso E; Martin C; Aranda I; Romero S
    Case Rep Med; 2009; 2009():598741. PubMed ID: 19746203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant transient pleural transudate: a sign of early lymphatic tumoral obstruction.
    Fernandez C; Martín C; Aranda I; Romero S
    Respiration; 2000; 67(3):333-6. PubMed ID: 10867607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Accuracy of Thoracic Ultrasonography to Differentiate Transudative From Exudative Pleural Effusion.
    Shkolnik B; Judson MA; Austin A; Hu K; D'Souza M; Zumbrunn A; Huggins JT; Yucel R; Chopra A
    Chest; 2020 Aug; 158(2):692-697. PubMed ID: 32194059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transudative malignant pleural effusions: prevalence and mechanisms.
    Ashchi M; Golish J; Eng P; O'Donovan P
    South Med J; 1998 Jan; 91(1):23-6. PubMed ID: 9438397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple laboratory measurement for discrimination of transudative and exudative pleural effusion: pleural viscosity.
    Yetkin O; Tek I; Kaya A; Ciledag A; Numanoglu N
    Respir Med; 2006 Jul; 100(7):1286-90. PubMed ID: 16305823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic principles in pleural disease.
    Light RW
    Eur Respir J; 1997 Feb; 10(2):476-81. PubMed ID: 9042652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Case of Lung Adenocarcinoma with Marked Improvement of Pulmonary Lymphangitic Carcinomatosis by Adding Bevacizumab to Cisplatin and Pemetrexed.
    Natsume M; Honda T; Haruyama T; Ishihara M; Fukasawa Y; Sakamoto T; Tanzawa S; Usui R; Ota S; Ichikawa Y; Watanabe K; Seki N
    Case Rep Oncol; 2017; 10(3):1065-1069. PubMed ID: 29515397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transudative pleural effusion of malignant etiology: Rare but real.
    Johnson L; Fakih HA; Daouk S; Saleem S; Ataya A
    Respir Med Case Rep; 2017; 20():188-191. PubMed ID: 28316930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphangitic carcinomatosis as the initial manifestation of primary signet-ring cell adenocarcinoma of the lung: A case report.
    Corredor-Orlandelli D; Vargas L
    Rare Tumors; 2023; 15():20363613231164017. PubMed ID: 36937819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytologically proved malignant pleural effusions: distribution of transudates and exudates.
    Assi Z; Caruso JL; Herndon J; Patz EF
    Chest; 1998 May; 113(5):1302-4. PubMed ID: 9596310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent Large Volume Malignant Pleural Effusion in a Patient With Renal Cell Carcinoma.
    Hutchinson AH; Fakhouri EW; Raudales J
    Cureus; 2021 Feb; 13(2):e13593. PubMed ID: 33815993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of exfoliative cell cytology in the diagnosis of exudative pleural effusions.
    Tetikkurt C; Yılmaz N; Tetikkurt S; Gundogdu Ş; Disci R
    Monaldi Arch Chest Dis; 2018 Sep; 88(3):944. PubMed ID: 30203633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the clinical significance of transudative malignant pleural effusion?
    Ryu JS; Ryu ST; Kim YS; Cho JH; Lee HL
    Korean J Intern Med; 2003 Dec; 18(4):230-3. PubMed ID: 14717231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopontin and C-reactive protein in Egyptian patients affected with tuberculous and malignant pleural effusion.
    Elsammak M MY; Morsi TS; Khamis HI; Ragab MS; Zaki MA; Abdel-Hadi M; Hassan HA
    Ann Clin Biochem; 2007 May; 44(Pt 3):264-72. PubMed ID: 17456294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of pleural fluid thiol/disulphide homoeostasis in the differentiation between transudative and exudative pleural effusions.
    Gormeli Kurt N; Gokhan S; Erel O; Gunes C; Kahraman AF; Ozhasenekler A
    Int J Clin Pract; 2021 Apr; 75(4):e14051. PubMed ID: 33492739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parietal Pleural Lymphatic Blockage by Anthracotic Nodule Laden Macrophage, Leading Cause of Pleural Effusion in Anthracosis.
    Mirsadraee M
    Tanaffos; 2023 Mar; 22(3):341-343. PubMed ID: 38638385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Massive pleural effusions from prostatic lymphangitic carcinomatosis: resolution with endocrine therapy.
    Heffner JE; Duffey DJ; Schwarz MI
    Arch Intern Med; 1982 Feb; 142(2):375-6. PubMed ID: 7059263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic value of pleural fluid cytologic examination].
    Zablockis R; Nargela R
    Medicina (Kaunas); 2002; 38(12):1171-8. PubMed ID: 12552157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transudative Pleural Effusion Associated with Extramedullary Hematopoiesis.
    Enokida K; Tomomatsu K; Okada N; Takeuchi T; Takihara T; Amaki J; Hayama N; Oguma T; Aoki T; Asano K
    Intern Med; 2021 Feb; 60(3):449-452. PubMed ID: 32963151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differential diagnosis between exudate and transudate in pleural effusion].
    Vázquez F; Michelángelo H; Trevisani H; González F; de Quiros B
    Medicina (B Aires); 1996; 56(3):223-30. PubMed ID: 9035477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.